Literature DB >> 22682225

Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression.

Joel T Haas1, Ji Miao, Dipanjan Chanda, Yanning Wang, Enpeng Zhao, Mary E Haas, Matthew Hirschey, B Vaitheesvaran, Robert V Farese, Irwin J Kurland, Mark Graham, Rosanne Crooke, Fabienne Foufelle, Sudha B Biddinger.   

Abstract

Dissecting the role of insulin in the complex regulation of triglyceride metabolism is necessary for understanding dyslipidemia and steatosis. Liver insulin receptor knockout (LIRKO) mice show that in the physiological context of feeding, hepatic insulin signaling is not required for the induction of mTORC1, an upstream activator of the lipogenic regulator, SREBP-1c. Feeding induces SREBP-1c mRNA in LIRKO livers, though not to the extent observed in controls. A high fructose diet also partially induces SREBP-1c and lipogenic gene expression in LIRKO livers. Insulin signaling becomes more important in the pathological context of obesity, as knockdown of the insulin receptor in ob/ob mice, a model of Type 2 diabetes, using antisense oligonucleotides, abolishes the induction of SREBP-1c and its targets by obesity and ameliorates steatosis. Thus, insulin-independent signaling pathways can partially compensate for insulin in the induction of SREBP-1c by feeding but the further induction by obesity/Type 2 diabetes is entirely dependent upon insulin.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22682225      PMCID: PMC3383842          DOI: 10.1016/j.cmet.2012.05.002

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  46 in total

1.  Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice.

Authors:  I Shimomura; M Matsuda; R E Hammer; Y Bashmakov; M S Brown; J L Goldstein
Journal:  Mol Cell       Date:  2000-07       Impact factor: 17.970

2.  Liver-specific mRNA for Insig-2 down-regulated by insulin: implications for fatty acid synthesis.

Authors:  Daisuke Yabe; Ryutaro Komuro; Guosheng Liang; Joseph L Goldstein; Michael S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-06       Impact factor: 11.205

3.  Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes.

Authors:  M Foretz; C Guichard; P Ferré; F Foufelle
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Stimulating effects of low-dose fructose on insulin-stimulated hepatic glycogen synthesis in humans.

Authors:  K F Petersen; D Laurent; C Yu; G W Cline; G I Shulman
Journal:  Diabetes       Date:  2001-06       Impact factor: 9.461

5.  Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction.

Authors:  M D Michael; R N Kulkarni; C Postic; S F Previs; G I Shulman; M A Magnuson; C R Kahn
Journal:  Mol Cell       Date:  2000-07       Impact factor: 17.970

6.  The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis.

Authors:  Shaodong Guo; Kyle D Copps; Xiaocheng Dong; Sunmin Park; Zhiyong Cheng; Alessandro Pocai; Luciano Rossetti; Mini Sajan; Robert V Farese; Morris F White
Journal:  Mol Cell Biol       Date:  2009-07-13       Impact factor: 4.272

7.  Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis.

Authors:  Luke J Engelking; Hiroshi Kuriyama; Robert E Hammer; Jay D Horton; Michael S Brown; Joseph L Goldstein; Guosheng Liang
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

8.  Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulin-resistant states.

Authors:  Mary L Standaert; Mini P Sajan; Atsushi Miura; Yoshinori Kanoh; Hubert C Chen; Robert V Farese; Robert V Farese
Journal:  J Biol Chem       Date:  2004-04-06       Impact factor: 5.157

9.  Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice.

Authors:  Takashi Matsuzaka; Hitoshi Shimano; Naoya Yahagi; Michiyo Amemiya-Kudo; Hiroaki Okazaki; Yoshiaki Tamura; Yoko Iizuka; Ken Ohashi; Sachiko Tomita; Motohiro Sekiya; Alyssa Hasty; Yoshimi Nakagawa; Hirohito Sone; Hideo Toyoshima; Shun Ishibashi; Jun-Ichi Osuga; Nobuhiro Yamada
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

10.  Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression.

Authors:  Renaud Dentin; Jean-Paul Pégorier; Fadila Benhamed; Fabienne Foufelle; Pascal Ferré; Véronique Fauveau; Mark A Magnuson; Jean Girard; Catherine Postic
Journal:  J Biol Chem       Date:  2004-02-25       Impact factor: 5.157

View more
  91 in total

1.  Single administration of recombinant IL-6 restores the gene expression of lipogenic enzymes in liver of fasting IL-6-deficient mice.

Authors:  A L Gavito; R Cabello; J Suarez; A Serrano; F J Pavón; M Vida; M Romero; V Pardo; D Bautista; S Arrabal; J Decara; A L Cuesta; A M Valverde; F Rodríguez de Fonseca; E Baixeras
Journal:  Br J Pharmacol       Date:  2016-02-22       Impact factor: 8.739

2.  Alpha-lipoic acid attenuates insulin resistance and improves glucose metabolism in high fat diet-fed mice.

Authors:  Yi Yang; Wang Li; Yang Liu; Yan Li; Ling Gao; Jia-jun Zhao
Journal:  Acta Pharmacol Sin       Date:  2014-08-25       Impact factor: 6.150

3.  FoxO1 Is Required for Most of the Metabolic and Hormonal Perturbations Produced by Hepatic Insulin Receptor Deletion in Male Mice.

Authors:  Alisha V Ling; Mary E Gearing; Ivana Semova; Dong-Ju Shin; Rebecca Clements; Zon W Lai; Sudha B Biddinger
Journal:  Endocrinology       Date:  2018-03-01       Impact factor: 4.736

4.  Hepatic oxidative stress promotes insulin-STAT-5 signaling and obesity by inactivating protein tyrosine phosphatase N2.

Authors:  Esteban N Gurzov; Melanie Tran; Manuel A Fernandez-Rojo; Troy L Merry; Xinmei Zhang; Yang Xu; Atsushi Fukushima; Michael J Waters; Matthew J Watt; Sofianos Andrikopoulos; Benjamin G Neel; Tony Tiganis
Journal:  Cell Metab       Date:  2014-06-19       Impact factor: 27.287

5.  Liver clock protein BMAL1 promotes de novo lipogenesis through insulin-mTORC2-AKT signaling.

Authors:  Deqiang Zhang; Xin Tong; Blake Arthurs; Anirvan Guha; Liangyou Rui; Avani Kamath; Ken Inoki; Lei Yin
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

6.  ChREBP regulates fructose-induced glucose production independently of insulin signaling.

Authors:  Mi-Sung Kim; Sarah A Krawczyk; Ludivine Doridot; Alan J Fowler; Jennifer X Wang; Sunia A Trauger; Hye-Lim Noh; Hee Joon Kang; John K Meissen; Matthew Blatnik; Jason K Kim; Michelle Lai; Mark A Herman
Journal:  J Clin Invest       Date:  2016-09-26       Impact factor: 14.808

7.  Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism.

Authors:  Tara C Brennan-Speranza; Holger Henneicke; Sylvia J Gasparini; Katharina I Blankenstein; Uta Heinevetter; Victoria C Cogger; Dmitri Svistounov; Yaqing Zhang; Gregory J Cooney; Frank Buttgereit; Colin R Dunstan; Caren Gundberg; Hong Zhou; Markus J Seibel
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

Review 8.  Regulation of Glucose Production in the Pathogenesis of Type 2 Diabetes.

Authors:  Ashot Sargsyan; Mark A Herman
Journal:  Curr Diab Rep       Date:  2019-08-03       Impact factor: 4.810

Review 9.  COUP-TFII revisited: Its role in metabolic gene regulation.

Authors:  Usman M Ashraf; Edwin R Sanchez; Sivarajan Kumarasamy
Journal:  Steroids       Date:  2018-11-24       Impact factor: 2.668

10.  Decreased genetic dosage of hepatic Yin Yang 1 causes diabetic-like symptoms.

Authors:  Francisco Verdeguer; Sharon M Blättler; John T Cunningham; Jessica A Hall; Helen Chim; Pere Puigserver
Journal:  Mol Endocrinol       Date:  2014-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.